Congenital Heart Disease (CHD), known locally in Indonesia as Penyakit Jantung Bawaan (PJB), remains a significant public health challenge, contributing to high neonatal mortality rates across the archipelago. While the precise underlying causes of these cardiac abnormalities often remain elusive to medical science, healthcare experts emphasize that several modifiable risk factors during pregnancy can be managed to reduce the incidence of children born with these life-threatening conditions. Dr. Rizky Adriansyah, MKed, a pediatric specialist and the Chairperson of the Cardiology Coordination Unit of the Indonesian Pediatric Society (IDAI), recently highlighted that although the relationship between certain behaviors and CHD is not always one of direct cause-and-effect, the identification of risk factors provides a critical window for preventative intervention.
During a comprehensive webinar held on Tuesday, February 14, 2023, dr. Rizky explained that while a definitive cause for most CHD cases cannot be pinpointed, medical literature has increasingly focused on three primary risk factors that manifest during the gestational period. These include maternal infections such as Rubella, a lack of essential nutrients—specifically folic acid—and the consumption of certain medications, such as anti-seizure drugs, by the mother during pregnancy. These factors are known to interfere with the complex biological processes involved in the formation of the fetal heart, which occurs very early in the first trimester.
The Critical Window of Fetal Development and Risk Mitigation
The development of the human heart is an intricate process that begins shortly after conception. By the time a woman realizes she is pregnant, the foundational structures of the heart are often already formed. This biological timeline underscores why preventative measures must be prioritized even before conception or in the earliest stages of pregnancy. Dr. Rizky noted that while lifestyle choices such as smoking and alcohol consumption have traditionally been linked to CHD, the medical community frequently encounters cases where mothers who avoided these substances still gave birth to infants with cardiac defects. This reality suggests a multifaceted interplay of genetics and environmental exposures that requires a broader approach to maternal health.
To combat these risks, the medical community advocates for a proactive vaccination strategy. Ensuring that women of childbearing age receive the Rubella vaccine is paramount, as the virus is a well-documented teratogen that can lead to severe structural defects in a developing fetus. Furthermore, the role of nutrition cannot be overstated. Folic acid supplementation is vital for DNA synthesis and repair; a deficiency during the early weeks of pregnancy is strongly associated not only with neural tube defects but also with various forms of congenital heart disease. Dr. Rizky emphasized that once a child is born with a heart defect, the opportunity for primary prevention has passed, shifting the medical focus toward early detection and surgical or medical management.
Statistical Overview: The Burden of CHD in Indonesia
The impact of Congenital Heart Disease on Indonesia’s public health landscape is profound. Data from 2017 indicates that CHD is the second leading cause of neonatal death in the country, accounting for approximately 17 percent of all fatalities in the newborn period, surpassed only by complications arising from prematurity. According to the World Health Organization (WHO), the global prevalence of CHD is roughly one in every 100 live births. Of these cases, approximately 25 percent are classified as "critical" CHD, meaning the infant will require surgical intervention or catheterization within the first year—often within the first few days—of life to survive.
In the Indonesian context, the sheer volume of cases presents a logistical and clinical challenge. With a birth rate of approximately 4.4 to 4.8 million babies per year, it is estimated that 40,000 to 50,000 Indonesian infants are born with CHD annually. However, dr. Rizky pointed out a harrowing reality: less than 50 percent of these cases are currently receiving adequate medical or surgical treatment. This treatment gap is the result of a complex synergy of factors, including limited geographical access to specialized cardiac centers, a shortage of pediatric cardiologists and cardiovascular surgeons, inadequate diagnostic equipment in remote regions, and a general lack of public awareness regarding the symptoms of heart disease in infants.
Challenges in Diagnosis and the Role of Early Screening
One of the most significant hurdles in improving survival rates for children with CHD in Indonesia is the delay in diagnosis. Many infants are discharged from birth facilities appearing healthy, only to deteriorate days later at home when the ductus arteriosus—a fetal blood vessel—closes. To address this, dr. Rizky and IDAI promote the use of simple, cost-effective screening tools. Pulse oximetry screening (POS) has emerged as a highly sensitive and non-invasive method for detecting critical CHD. By measuring oxygen saturation in the right hand and either foot, healthcare providers can identify hypoxemia that may indicate an underlying heart defect before the infant shows outward clinical signs of distress.
In addition to oximetry, the traditional physical examination remains a cornerstone of pediatric care. The presence of a heart murmur, detected via a stethoscope, should immediately prompt further investigation. However, dr. Rizky warned that the absence of a murmur does not necessarily rule out a critical heart defect. Clinical symptoms such as poor weight gain, difficulty feeding, rapid breathing, or a bluish tint to the skin (cyanosis) are red flags that necessitate an urgent echocardiography—an ultrasound of the heart that provides a definitive diagnosis of structural abnormalities.
Strengthening the Healthcare Ecosystem and Primary Care
To bridge the gap in CHD care, there is an urgent need to empower primary healthcare providers, including midwives and general practitioners at the Puskesmas (community health center) level. Since midwives attend a large percentage of births in Indonesia, their ability to perform basic cardiac screening is vital. Dr. Rizky noted that a pulse oximetry check takes less than five minutes but can be the difference between life and death. Education initiatives, such as the YouTube channel "Sehatkan Jantung Anak Indonesia," serve as a digital resource to train healthcare workers and educate parents on what to look for during the first week of a child’s life.
The Indonesian Ministry of Health has recently signaled a commitment to transforming the nation’s health services, which includes the expansion of cardiac care capabilities across all provinces. Currently, specialized cardiac surgeries are heavily concentrated in major urban centers like Jakarta, particularly at the National Cardiovascular Center Harapan Kita. For families in eastern Indonesia or remote parts of Sumatra and Kalimantan, the journey to access life-saving surgery is often fraught with financial and logistical barriers. Experts argue that decentralizing cardiac care and improving the referral system under the National Health Insurance (JKN) scheme are essential steps toward reducing the mortality rate associated with CHD.
Socio-Economic Implications and the Path Forward
The long-term implications of untreated or late-treated CHD extend beyond individual health, affecting the socio-economic fabric of the nation. Children with chronic heart conditions often face developmental delays and require lifelong medical supervision, placing a significant emotional and financial burden on families. From a national perspective, as Indonesia strives toward its "Golden Indonesia 2045" vision, ensuring the health of its youngest citizens is a prerequisite for a productive future workforce.
The analysis of the current situation suggests that while medical technology for treating CHD has advanced significantly, the "bottleneck" remains in the early detection and the distribution of medical expertise. If Indonesia can increase its detection rate through mandatory newborn screening and expand its surgical capacity, the 17 percent neonatal mortality rate attributed to heart defects could be drastically reduced.
In conclusion, the fight against Congenital Heart Disease in Indonesia requires a two-pronged approach: rigorous prevention through maternal health optimization and an aggressive strategy for early diagnosis and intervention. By focusing on Rubella immunization, folic acid fortification, and the widespread adoption of simple screening technologies like pulse oximetry, the healthcare system can better protect its most vulnerable members. As dr. Rizky Adriansyah emphasized, while the causes may be complex and often unknown, the path to saving lives is clear—it begins with awareness, moves through early detection, and ends with timely, accessible medical care for every Indonesian child, regardless of where they are born.
